12 March 2020
Blueberry Therapeutics announces new Clinical Science Lead
Blueberry Therapeutics are delighted to welcome Kerry Nield as Clinical Science Lead, with responsibility for clinical trial design and pipeline implementation including clinical scientific expertise, clinical strategy and product development planning.
Kerry has over 17 years’ experience in pharmaceutical and clinical development with a particular focus in dermatology, and has previously held senior positions at Renovo, and more recently, Smerud Medical Research. Kerry has a PhD in Molecular Genetics from the University of Manchester and a BSc (Hons) in Human Genetics from University College London.